CA9 and colorectal carcinoma: In order to evaluate the potential of the novel peptide CaIX-P1 for targeting human carbonic anhydrase IX we investigated its binding characteristics under conditions of differential CAIX expression in HCT116 and HT29 human colorectal carcinoma cells.